National report — A proposed $3.2 billion merger of Botox-maker Allergan and breast-implant maker Inamed would ultimately benefit dermatologists, an Allergan official says.
Addressing Disparities in Skin-Aging Prevention Among Women of Color
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Botulinum Toxin, Dermal Fillers Generally Effective and Well-Tolerated in Skin of Color Populations
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Muneeb Shah, DO: Behind the Scenes of Launching a Skin Care Brand
Allergan Aesthetics Launches New Book to Bring More Awareness to Ethics in Aesthetics